Pharmaceutical

UK MHRA approves Advanz Pharma antibiotic for complex infections

The UK MHRA has approved Advanz Pharma’s combined antibiotic, cefepime/enmetazobactam, to treat complicated infections.

Apr 7, 2024 - 00:00
UK MHRA approves Advanz Pharma antibiotic for complex infections
The UK MHRA has approved Advanz Pharma’s combined antibiotic, cefepime/enmetazobactam, to treat complicated infections.
Read the original article

Tags:

Previous Article

Caris and Merck KGaA link to develop ADCs for cancer treatment

Next Article

Q&A: BARDA wants to back tech that can combat multiple infections, says director

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Liquidia’s YUTREPIA inhalation powder gains tentative FDA approval

Liquidia’s YUTREPIA inhalation powder gains tentative F...

Aug 21, 2024

Tagrisso plus chemo has FDA priority review for metastatic EGFRm NSCLC

Tagrisso plus chemo has FDA priority review for metasta...

Oct 17, 2023

CT-080 by First Condor Group for Solid Tumor: Likelihoo...

Oct 3, 2023